Cart
sales@molnova.com
TGX-221
CAS No. 663619-89-4
TGX-221( TGX221 | TGX 221 )
Catalog No. M15529 CAS No. 663619-89-4
A potent, selective PI3K p110β inhibitor with IC50 of 8.5 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 57 | In Stock |
|
| 2MG | 33 | In Stock |
|
| 5MG | 52 | In Stock |
|
| 10MG | 90 | In Stock |
|
| 25MG | 186 | In Stock |
|
| 50MG | 300 | In Stock |
|
| 100MG | 454 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTGX-221
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective PI3K p110β inhibitor with IC50 of 8.5 nM.
-
DescriptionA potent, selective PI3K p110β inhibitor with IC50 of 8.5 nM; weakly inhibits p110δ (IC50=211 nM), and no activity against p110α (IC50>1 uM); inhibits platelet-ECC interaction, platelet aggregation and platelet-granulocyte binding; shows anti-thrombotic effectt devoid of other cardiovascular actions in rats.
-
In Vitro——
-
In Vivo——
-
SynonymsTGX221 | TGX 221
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
Recptorp110α|p110β|p110γ|p110δ
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number663619-89-4
-
Formula Weight364.4409
-
Molecular FormulaC21H24N4O2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C1C=C(N2CCOCC2)N=C3N1C=C(C)C=C3C(NC4=CC=CC=C4)C
-
Chemical Name4H-Pyrido[1,2-a]pyrimidin-4-one, 7-methyl-2-(4-morpholinyl)-9-[1-(phenylamino)ethyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Frazzetto M, et al. Biochem J. 2008 Sep 15;414(3):383-90.
2. Sturgeon SA, et al. Eur J Pharmacol. 2008 Jun 10;587(1-3):209-15.
3. Chaussade C, et al. Biochem J. 2007 Jun 15;404(3):449-58.
4. Straub A, et al. Thromb Haemost. 2008 Mar;99(3):609-15.
molnova catalog
related products
-
PP121
A multitargeted, dual tyrosine and PI3K kinase inhibitor of PDGFR, Hck, mTOR, VEGFR2, Src and Abl.
-
mTOR inhibitor 9d
mTOR inhibitor 9d is a dual inhibitor of the protein kinases mTOR and PI3K with an mTOR IC50 value of 0.31 nm, and can be used for the treatment of leukemia, skin cancer, breast cancer, lung cancer and colon cancer.
-
Loureirin A
Loureirin A has an inhibitory effect on platelet activation perhaps through an impairment of PI3K/Akt signaling.Loureirin A negatively affects agonist-induced platelet aggregation such as collagen collagen-related peptide (CRP) ADP and thrombin.
